Pharma Journalist - Page 74 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Dupixent Approved in U.S. as First Targeted Therapy in Over a Decade for Chronic Hives

BigHat and Lilly Team Up to Develop AI-Driven Antibody Therapies

Cellino and Karis Bio Partner to Develop First Nebula-Powered iPSC Therapy for Heart Disease

Boehringer Ingelheim and Cue Biopharma Team Up on Next-Gen Autoimmune Therapies

EU Approves Roche’s Columvi as First Bispecific Antibody for DLBCL After Initial Treatment

Pfizer Shares Update on Oral GLP-1 Candidate Danuglipron

REVEAL GENOMICS and Ona Therapeutics Partner on Next-Gen Cancer Therapy

Ironwood Pharmaceuticals Issues Clinical and Regulatory Update on Apraglutide

Bristol Myers Squibb Shares Phase 3 ODYSSEY-HCM Trial Update

Valneva Secures First IXCHIQ Approval in Chikungunya-Endemic Country